Showing results (3031-3040 of 6,794) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|October 19, 2016
Differences in the Association of Nocturia and Functional Outcomes of Sleep by Age and Gender: A Cross-sectional, Population-based StudyCamille P Vaughan, Constance H Fung, Alison J Huang, et al.
Clinical Therapeutics|October 19, 2016
Pulmonary Embolism Inpatients Treated With Rivaroxaban Had Shorter Hospital Stays and Lower Costs Compared With WarfarinJay M Margolis, Steven Deitelzweig, Jeffrey Kline, et al.
Clinical Therapeutics|November 27, 2016
Evaluation of 16 genotype-guided Warfarin Dosing Algorithms in 310 Korean Patients Receiving Warfarin Treatment: Poor Prediction Performance in VKORC1 1173C CarriersMina Yang, Rihwa Choi, June Soo Kim, et al.
Clinical Therapeutics|November 28, 2016
Glycemic Control and Weight Outcomes for Exenatide Once Weekly Versus Liraglutide in Patients with Type 2 Diabetes: A 1-Year Retrospective Cohort AnalysisCarrie McAdam-Marx, Hiep Nguyen, Marisa B Schauerhamer, et al.
Clinical Therapeutics|October 7, 2016
Comparative Pharmacokinetic Analysis of Thiamine and Its Phosphorylated Metabolites Administered as Multivitamin PreparationsWan-Su Park, Jongtae Lee, Taegon Hong, et al.
Clinical Therapeutics|November 22, 2016
Value of Propensity Score Matching for Equalizing Comparator Groups in Observational Database Studies: A Case Study in Anti-infectivesC Daniel Mullins, Frank R Ernst, Michelle R Krukas, et al.
Clinical Therapeutics|December 4, 2016
Pharmacovigilance and Biomedical Informatics: A Model for Future DevelopmentPaul Beninger, Michael A Ibara
Clinical Therapeutics|December 7, 2016
Unsolved, Forgotten, and Ignored Features of the Placebo Response in MedicinePaul Enck, Sibylle Klosterhalfen, Katja Weimer
Clinical Therapeutics|October 4, 2016
A Review of Ferric Pyrophosphate Citrate (Triferic) Use in Hemodialysis PatientsTyler Albright, Akram Al-Makki, Rabih Kalakeche, et al.
Clinical Therapeutics|October 4, 2016
Pharmacodynamic Effects of Single and Multiple Doses of Empagliflozin in Patients With Type 2 DiabetesTim Heise, Jens Jordan, Christoph Wanner, et al.
Pageof 680